The Society of Hematologic Oncology invites industry supporters to participate during the 2019 annual meeting. The program affords our industry partners the opportunity to interact with nearly 1,500 of the world’s leaders in the hematologic oncology field.
For more information regarding exhibit and support opportunities, just click the link to download the Industry Prospectus and Individual Applications.
You may also contact Belinda Melder, the industry coordinator for the meeting at 1.281.364.7387 x201 or via email at email@example.com. If you have already reserved an exhibit space or would like more information about exhibit services or products, you may connect directly to Freeman Online to help you prepare for a successful face-to-face event.
The conference committee wishes to express appreciation to the following companies:
Astellas Pharma US, Inc • Gilead Sciences, Inc • Janssen Biotech, Inc. • Novartis Oncology • RedEdMed
Alexion • BMS/Pfizer • Jazz Pharmaceuticals, Inc. • Pfizer • Pharmacyclics LLC • Seattle Genetics, Inc • Servier • Teva Oncology
Elsevier • MD Anderson Cancer Center